SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 38 filers reported holding SINOVAC BIOTECH LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,000 | -83.3% | 274 | -84.5% | 0.00% | – |
| Q3 2017 | $12,000 | 0.0% | 1,771 | -0.4% | 0.00% | -100.0% |
| Q2 2017 | $12,000 | -47.8% | 1,778 | -55.6% | 0.00% | 0.0% |
| Q4 2016 | $23,000 | -52.1% | 4,003 | -50.9% | 0.00% | -66.7% |
| Q3 2016 | $48,000 | +1100.0% | 8,154 | +1064.9% | 0.00% | – |
| Q2 2016 | $4,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |